The endothelin receptor antagonist decreases ischemia/reperfusion-induced tumor necrosis factor production in isolated rat hearts
- 28 April 2005
- journal article
- other
- Published by Elsevier in International Journal of Cardiology
- Vol. 100 (3) , 495-498
- https://doi.org/10.1016/j.ijcard.2004.03.051
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Endothelium and the lipid metabolism: the current understandingInternational Journal of Cardiology, 2003
- Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?International Journal of Cardiology, 2002
- ETA receptor blockade improves post-ischaemic functional recovery in ‘hibernating’ rat myocardiumClinical Science, 2002
- Differential effects of endothelin-1 on isolated working rat hearts before and after ischaemia and reperfusionClinical Science, 2002
- STRATEGIES TO MODULATE THE DELETERIOUS EFFECTS OF ENDOTHELIN IN HEPATIC ISCHEMIA-REPERFUSION1Transplantation, 2000
- Inhibition of cardiac tumor necrosis factor-α production by calcitonin gene-related peptide-mediated ischemic preconditioning in isolated rat heartsEuropean Journal of Pharmacology, 2000
- Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor α-stimulated vascular endothelial cellsEuropean Journal of Pharmacology, 1999
- Endothelin in myocardial ischaemia and reperfusionCardiovascular Research, 1997
- Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusionJournal of the American College of Cardiology, 1996
- Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines.Proceedings of the National Academy of Sciences, 1995